Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 3
1964 1
1970 2
1971 2
1972 3
1973 1
1974 3
1975 1
1976 1
1977 1
1980 1
1981 1
1983 2
1984 1
1985 1
1987 2
1988 1
1989 2
1990 1
1991 2
1992 4
1993 3
1994 2
1995 4
1996 6
1997 9
1998 8
1999 2
2000 3
2001 9
2002 7
2003 11
2004 16
2005 20
2006 16
2007 17
2008 25
2009 23
2010 24
2011 19
2012 19
2013 24
2014 27
2015 23
2016 27
2017 27
2018 31
2019 21
2020 50
2021 60
2022 65
2023 75
2024 67

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

696 results

Results by year

Filters applied: . Clear all
Page 1
Effectiveness of cefmetazole versus meropenem for invasive urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.
Hayakawa K, Matsumura Y, Uemura K, Tsuzuki S, Sakurai A, Tanizaki R, Shinohara K, Hashimoto T, Hase R, Matono T, Kato H, Mawatari M, Hara H, Hamada Y, Saito S, Ohmagari N, Doi Y. Hayakawa K, et al. Among authors: tsuzuki s. Antimicrob Agents Chemother. 2023 Oct 18;67(10):e0051023. doi: 10.1128/aac.00510-23. Epub 2023 Sep 13. Antimicrob Agents Chemother. 2023. PMID: 37702483 Free PMC article.
Real-world survival outcome comparing abiraterone acetate plus prednisone and enzalutamide for nonmetastatic castration-resistant prostate cancer.
Tsujino T, Tokushige S, Komura K, Fukuokaya W, Adachi T, Hirasawa Y, Hashimoto T, Yoshizawa A, Saruta M, Ohno T, Nakamori K, Maenosono R, Nishimura K, Yamazaki S, Uchimoto T, Yanagisawa T, Mori K, Urabe F, Tsuzuki S, Iwatani K, Yamamoto S, Takahara K, Inamoto T, Kimura T, Ohno Y, Shiroki R, Azuma H. Tsujino T, et al. Among authors: tsuzuki s. Cancer Med. 2023 Oct;12(19):19414-19422. doi: 10.1002/cam4.6536. Epub 2023 Sep 14. Cancer Med. 2023. PMID: 37706578 Free PMC article.
Adjuvant immunotherapy in patients with renal cell carcinoma and urothelial carcinoma: A systematic review and network meta-analysis.
Mori K, Yanagisawa T, Fukuokaya W, Iwatani K, Matsukawa A, Katayama S, Pradere B, Laukhtina E, Rajwa P, Moschini M, Albisinni S, Krajewski W, Cimadamore A, Del Giudice F, Teoh J, Urabe F, Kimura S, Murakami M, Tsuzuki S, Miki J, Miki K, Shariat SF, Kimura T; European Association of Urology-Young Academic Urologists Urothelial Carcinoma Working Group (EAU-YAU). Mori K, et al. Among authors: tsuzuki s. Int J Urol. 2024 Jan;31(1):25-31. doi: 10.1111/iju.15319. Epub 2023 Oct 15. Int J Urol. 2024. PMID: 37840031 Review.
The future of COVID-19 surveillance in Japan.
Tsuzuki S. Tsuzuki S. Lancet Infect Dis. 2023 Nov;23(11):1209-1210. doi: 10.1016/S1473-3099(23)00292-X. Epub 2023 Jun 30. Lancet Infect Dis. 2023. PMID: 37399830 No abstract available.
696 results